Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas

Laryngoscope

Volumn 106, Issue 2, 1996, Pages 190-195

  Nagai, M A ^a   Butugan, O ^b   Logullo, A ^a   Brentani, M M ^a  

^a Santa Casa de Misericórdia de Curitiba   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P53; RNA 18S; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYME; NASOPHARYNX FIBROMA; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; RNA ANALYSIS; SCHOOL CHILD; TUMOR BIOPSY;

ADOLESCENT; ADULT; ANGIOFIBROMA; CHILD; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GROWTH SUBSTANCES; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENES; RNA, MESSENGER; TURBINATES;

EID: 0030053966     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199602000-00016     Document Type: Article

References (32)

1. Sternberg SS. Pathology of juvenile nasopharyngeal angiofibroma-a lesion of adolescent males. Cancer. 1954;7:15-28.
2. Schiff M. Juvenile nasopharyngeal angiofibroma. Laryngoscope. 1959;49:981-1016.
3. Brentani MM, Butugan O, Oshima CTF, et al. Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope. 1989;99:398-401.
4. Gates GA, Rice DH, Koopmann CF, Jr. et al. Flutamide-induced regression of angiofibroma. Laryngoscope. 1992;102:641-644.
5. Shikani AH, Richtsmeier WL. Juvenile nasopharyngeal angiofibroma tumor models failure of androgens to stimulate growth in nude mice and in vitro. Arch Otorlaryngol Head Neck Surg. 1992;118:256-259.
6. Judge SM, Kanter AM. Relationship between androgen-induced cell proliferation and sensitivity to exogenous growth factors. Mol Endocrinol. 1988;2:375-381.
7. 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogen-regulated genes. Cell Growth Differ. 1994;5:919-935.
8. Kouhara H, Koga M, Kasayama S, et al. Transforming activity of a newly cloned androgen-induced growth factor. Oncogene. 1994;9:455-462.
9. Folkman J, Ling Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
10. Heldin C-H. Structural and functional studies on platelet-derived growth factor. EMBO J. 1992;11:4251-4259.
11. Scott J, Cowell J, Robertson ME, et al. Insulin-like growth factor II gene expression in Wilms' tumor and embryonic tissues. Nature. 1985;317:260-262.
12. Chandler JR, Moskowitz L, Goulding R, et al. Nasopharyngeal angiofibromas: staging and management. Ann Otol Rhinol Laryngol. 1984;93:322-329.
13. Nagai MA, Harb-Gama A, Oshima CTF, et al. Association of genetic alterations of c-myc, c-fos, and c/Ha-ras proto-oncogenes in colorectal tumors. Dis Colon Rectum. 1992;35:444-451.
14. Watt R, Staton LW, Marcu KB, et al. Nucleotide sequence of cloned cDNA of human c-myc. Oncogene. 1983;303:728.
15. Abraham JA, Whang JL, Tumolo A, et al. Human basic fibroblast growth factor: nucleotide sequence and gene organization. EMBO J. 1986;5:2523-2528.
16. Curran T, MacConnell WP, Straaten F, et al. Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homology of the v-fos gene from mouse and human cells. Mol Cell Biol. 1983;3:914-921.
17. Pagter-Holthuizen P, Höppener JWM, Jansen M, et al. Chromosomal localization and preliminary characterization of the human gene encoding insulin-like growth factor II. Human Genet. 1985;69:170-173.
18. Ferrara N. Houck K. Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
19. Banks L, Matlashewski G, Grawford, L. Isolation of human-p53-specific monoclonal antibodies and their use in the human of human p53 expression. Eur J Biochem. 1986;159:529-534.
20. Derynck R, Jarret JA. Chen EY, et al. Human transforming growth factor-complementary DNA sequence and expression in normal and transformed cells. Nature. 1985;316:701-705.
21. Betsholtz C, Johnsson A. Heldin C-H, et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature. 1986;320:695-699.
22. Josephs SF. Ratner L. Clarke MF, et al. Transforming potential of human c-sis nucleotide sequences encoding platelet-derived growth factor. Science. 1984;225:636-639.
23. 1: histochemical localization with antibodies to different epitopes. J Cell Biol. 1989;108:653-660.
24. Schiff M, Gonzalez A-M. Ong M, et al. Juvenile nasopharyngeal angiofibromas contain an angiogenic growth factor: basic FGF. Laryngoscope. 1992;102:940-945.
25. Pertovaara L. Kaipainen A. Mustone T, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem. 1994;269:6271-6274.
26. Battegay EJ. Rupp J, Iruela-Arispe L, et al. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF β-receptors. J Cell Biol. 1994;25:917-928.
27. 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993;90:10759-10763.
28. Jaye M, McConathy E, Drohan W. Modulation of the sis gene transcript during endothelial cell differentiation in vitro. Science. 1985;228:882-884.
29. Dameron KM, Volpert OV. Tainsky MA. et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994;265:1582-1584.
30. Tricoli JV, Rall LB, Karakousis CP. et al. Enhanced levels of insulin like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 1986;46:6169-6173.
31. Riier S, Johnson LA, Dobry CJ, et al. Relaxation of imprinted genes in human cancer. Nature. 1993;362:747-751.
32. Ringertz N. Pathology of malignant tumors arising in nasal and paranasal cavities and maxilla. Acta Otolaryngol (Stockh). 1938;26:157-173.